Use of Electroconvulsive Therapy for Catatonia in Down Syndrome Regression Disorder: A Systematic Review, Case Series, and Analysis
Authors:
- Kaidi KangKKKaidi Kang
- Elizabeth OeyEOElizabeth Oey
- Stephanie SantoroSSStephanie Santoro
- Catherine FranklinCFCatherine Franklin
- James LuccarelliJLJames Luccarelli
- Courtney HamiltonCHCourtney Hamilton
- Sarah MarlerSMSarah Marler
- Timothy AdegokeTATimothy Adegoke
- Jo Ellen WilsonJWJo Ellen Wilson
- Joshua Ryan SmithJSJoshua Ryan Smith
Open Access
- 28 August 2026
- journal article
- review article
- Published by Springer Nature in Journal of Autism and Developmental Disorders
- p. 1-11
Abstract
Purpose: Down syndrome regression disorder (DSRD) is a condition occurring in young people with Down syndrome. It is associated with functional decline, new onset psychopathology, and increased support needs. DSRD is often associated with catatonia, for which electroconvulsive therapy (ECT) is an effective treatment. However, there are scant studies to guide best practice in this area. Methods: We report a case series of 5 patients who have received ECT at Vanderbilt University Medical Center. A systematic review and analysis were conducted, combining this case series with previously reported data in the literature. Results: This analysis included data from 27 patients, 5 from the VUMC case series and a further 22 from 14 studies. Combining all patients from case series and the systematic review, there were 17 pre-ECT and 15 post-ECT Bush Francis Catatonia Rating Scale (BFCRS) scores reported from 7 sites/studies. The mean pre-ECT BFCRS score from all patients was 17.40 (SD = 5.72) and the mean post-ECT BFCRS score was 4.40 (SD = 5.26). A generalized estimating equations analysis revealed that there was a significant difference in the expected BFCRS score before and after receiving ECT treatment ( β = -13.00 with 95%, p < 0.001), suggesting that the ECT treatment had a significant effect on reducing the BFCRS scores. No severe adverse events were reported. Conclusion: ECT is associated with clinical improvement in patients with catatonia in the context of DSRD in this systematic review and analysis. More research is needed to provide a more robust evidence base.Keywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (1P50-HD103537)
This publication has 56 references indexed in Scilit:
- Hospitalizations for pediatric catatonia in neurodivergent and neurotypical patientsGeneral Hospital Psychiatry, 2025
- Longitudinal Symptom Burden and Pharmacologic Management of Catatonia in Autism With Intellectual Disability: An Observational StudyAutism Research, 2025
- A Case of Catatonia in a 37-Month-Old Child With Myelin Oligodendrocyte Glycoprotein-Antibody–Positive Acute Disseminated EncephalomyelitisJournal of the American Academy of Child & Adolescent Psychiatry, 2024
- Symptoms of Catatonia Observed in Down Syndrome Regressive Disorder: A Retrospective AnalysisJournal of Autism and Developmental Disorders, 2024
- Use of ECT in Autism Spectrum Disorder and/or Intellectual Disability: A Single Site Retrospective AnalysisJournal of Autism and Developmental Disorders, 2022
- Morbidity Due to Disparity in Pediatric Electroconvulsive TherapyJournal of the American Academy of Child & Adolescent Psychiatry, 2022
- Unexplained regression in Down syndrome: Management of 51 patients in an international patient databaseAmerican Journal of Medical Genetics Part A, 2022
- Catatonia in Children and Adolescents: A High Rate of Genetic ConditionsJournal of the American Academy of Child & Adolescent Psychiatry, 2018
- Estimates of the live births, natural losses, and elective terminations with Down syndrome in the United StatesAmerican Journal of Medical Genetics Part A, 2015
- Regression: Atypical Loss of Attained Functioning in Children and Adolescents with Down Syndrome2011